(4S,6R)-6-[(E)-2-[2-(4-Fluoro-3-Methylphenyl)-4,4,6,6-Tetramethyl-1-Cyclohexenyl]Ethenyl]-4-Hydroxyoxan-2-One

CAS: 132100-55-1

Ref. 3D-FF102931

Product Information

• Name: (4S,6R)-6-[(E)-2-[2-(4-Fluoro-3-Methylphenyl)-4,4,6,6-Tetramethyl-1-Cyclohexenyl]Ethenyl]-4-Hydroxyoxan-2-One
• Synonyms: Dalvastatin [USAN:INN], (+-)-(4R*,6S*)-6-((E)-2-(2-(4-Fluoro-m-tolyl)-4,4,6,6-tetramethyl-1-cyclohexen-1-yl)vinyl)tetrahydro-4-hydroxy-2H-pyran-2-one, 2H-Pyran-2-one, 6-(2-(2-(4-fluoro-3-methylphenyl)-4,4,6,6-tetramethyl-1-cyclohexen-1-yl)ethenyl)tetrahydro-4-hydroxy-, (4alpha,6beta(E))-(+-)-, Dalvastatina, Dalvastatina [INN-Spanish], Dalvastatine, Dalvastatine [INN-French], Dalvastatinum, Dalvastatinum [INN-Latin], Rg 12561, Unii-Zwe0X0Ig9D, 2H-Pyran-2-one, 6-((1E)-2-(2-(4-fluoro-3-methylphenyl)-4,4,6,6-tetramethyl-1-cyclohexen-1-yl)ethenyl)tetrahydro-4-hydroxy-, (4R,6S)-rel-

Description

(4S,6R)-6-[(E)-2-[2-(4-Fluoro-3-Methylphenyl)-4,4,6,6-Tetramethyl-1-Cyclohexenyl]Ethenyl]-4-Hydroxyoxan-2-One is a drug that belongs to the class of angiotensin system drugs. It is used to treat congestive heart failure by improving the blood supply to the heart muscle. The drug has been shown to have antihypertensive effects and improve symptoms in patients with congestive heart failure. Its mechanism of action is not fully understood; however, it may act by activating or blocking receptors for angiotensin II in various tissues or by inhibiting enzymes that break down angiotensin II. The drug also inhibits toll-like receptor 4 (TLR4), which plays a role in inflammation and autoimmune diseases such as choroidal neovascularization and prav

• Brand: Biosynth

Chemical properties

• Molecular weight: 386.5 g/mol
• Formula: C₂₄H₃₁FO₃
• Purity: Min. 95%
• InChI: InChI=1S/C24H31FO3/c1-15-10-16(6-9-21(15)25)19-13-23(2,3)14-24(4,5)20(19)8-7-18-11-17(26)12-22(27)28-18/h6-10,17-18,26H,11-14H2,1-5H3/b8-7+/t17-,18-/m1/s1
• InChI key: InChIKey=VDSBXXDKCUBMQC-HNGSOEQISA-N
• SMILES: Cc1cc(C2=C(/C=C/[C@@H]3C[C@@H](O)CC(=O)O3)C(C)(C)CC(C)(C)C2)ccc1F